Welcome to the EAS 2023 Interactive Program

Re-thinking Lipid Management in Patients with High- and Very-High Cardiovascular Risk - Industry Sponsored Session by Daiichi Sankyo. Join us for an informative session on current clinical practice around dyslipidemia management in patients with high- and very-high risk in Europe, featuring a panel of leading experts who will provide updates on recent therapeutic options, insights from the SANTORINI and MILOS trials on use of lipid-lowering therapies in clinical practice, and the growing importance of combination therapy as the new standard of care. You can look forward to an engaging Q&A session and panel discussion, where you will have the opportunity to ask questions and gain valuable insights into the latest developments in lipid management.